The Scientist

» biotech

Most Recent

In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.

0 Comments

Biotech stocks fell in response to the news. 

0 Comments

image: Equivocal Findings of Alzheimer’s Trial Using Young Blood

Equivocal Findings of Alzheimer’s Trial Using Young Blood

By Catherine Offord | November 6, 2017

A team of Stanford University researchers say that administering young people’s blood plasma to Alzheimer’s patients could improve cognitive function, but the results have been criticized.

0 Comments

image: Flux and Uncertainty in the CRISPR Patent Landscape

Flux and Uncertainty in the CRISPR Patent Landscape

By Aggie Mika | October 1, 2017

The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.

0 Comments

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By Claire Asher | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

image: CAR T-Cell Trials Boast Promising Results

CAR T-Cell Trials Boast Promising Results

By Diana Kwon | June 6, 2017

The results of two small clinical trials show that the immunotherapy is effective for multiple myeloma patients, at least in the near term.

0 Comments

image: Learning from Iceland’s Model for Genetic Research

Learning from Iceland’s Model for Genetic Research

By Catherine Offord | June 1, 2017

The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.

1 Comment

image: Former Head of Genzyme Dies

Former Head of Genzyme Dies

By Diana Kwon | May 15, 2017

Henri Termeer helped usher the biotech company into an industry behemoth.

0 Comments

image: Life Science Leaders Meet at White House

Life Science Leaders Meet at White House

By Kerry Grens | May 8, 2017

Heads of academia and industry mingled with the vice president and the secretary of Health and Human Services at a biotech summit.

0 Comments

image: Opinion: Preparing for Potential Disasters

Opinion: Preparing for Potential Disasters

By Larissa Paschyn | January 25, 2017

How to increase the resiliency of biotechnology organizations in the face of emergency risks

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. Dartmouth Professor Investigated for Sexual Misconduct Retires
  4. North American Universities Increasingly Cancel Publisher Packages